Opioid-fighting startup lands CEO, COO with deep pharmaceutical expertise

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

The Neurotechnology Innovations Translator LLC turned to pharmaceutical experts on both coasts, asking them to evaluate the promise of pain-fighting technology that reduces the need for opioid prescriptions. They both were so excited about it they joined as the startup’s leadership team.

CEO Gregory Fiore and COO Bryan Jones started this month at Sollis Therapeutics Inc., the second company created with seed funding from the public-private commercialization center. Fiore, a non-practicing physician and pharmaceutical consultant who developed drug safety products, is moving to Central Ohio from Boston. Jones is a geneticist who had led cancer pain programs at Sorrento Therapeutics Inc. (NASDAQ:SRNE) in San Diego.

Click here to read the complete article.

Originally published May 3, 2017.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: